Lecturio - Pharmacology

1. 01. Antimicrobial Pharmacology/01.01 Overview – Cell Wall Synthesis Inhibitors (Antibiotics).mp46.9MB
2. 01. Antimicrobial Pharmacology/01.02 Penicillins – Cell Wall Synthesis Inhibitors (Antibiotics).mp430.16MB
3. 01. Antimicrobial Pharmacology/01.03 Cephalosporins – Cell Wall Synthesis Inhibitors (Antibiotics).mp420.16MB
4. 01. Antimicrobial Pharmacology/01.04 Carbapenems – Cell Wall Synthesis Inhibitors (Antibiotics).mp46.95MB
5. 01. Antimicrobial Pharmacology/01.05 Vancomycin, Bacitracin and Daptomycin – Cell Wall Synthesis Inhibitors (Antibiotics).mp419.69MB
6. 01. Antimicrobial Pharmacology/01.06 Overview – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp433.48MB
7. 01. Antimicrobial Pharmacology/01.07 Linezolid, Streptogramins and Chloramphenicol – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp430.75MB
8. 01. Antimicrobial Pharmacology/01.08 Macrolides and Ketolides – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp424.42MB
9. 01. Antimicrobial Pharmacology/01.09 Tetracyclines – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp423.32MB
10. 01. Antimicrobial Pharmacology/01.10 Aminoglycosides – Bacterial Protein Synthesis Inhibitors (Antibiotics).mp436.91MB
11. 01. Antimicrobial Pharmacology/01.11 Quiz Questions and Case Studies – Antibacterial Agents (Antibiotics).mp447.83MB
12. 01. Antimicrobial Pharmacology/02.01 Overview – Antimetabolites.mp45.57MB
13. 01. Antimicrobial Pharmacology/02.02 Sulfonamides, Trimethoprim and Fluoroquinolones – Antimetabolites.mp456.7MB
14. 01. Antimicrobial Pharmacology/02.03 Case Studies – Antimetabolites.mp422.13MB
15. 01. Antimicrobial Pharmacology/02.04 Overview – Antimycobacterial Agents.mp46.48MB
16. 01. Antimicrobial Pharmacology/02.05 Antituberculosis Drugs – Antimycobacterial Agents.mp441.65MB
17. 01. Antimicrobial Pharmacology/02.06 Treatment Regimens for Mycobacterium Tuberculosis, Leprosy and Other Infections – Antimycobacterial Agents.mp424.91MB
18. 01. Antimicrobial Pharmacology/02.07 Case Studies – Antimycobacterial Agents.mp438.87MB
19. 01. Antimicrobial Pharmacology/03.01 Overview – Antifungals.mp44.88MB
20. 01. Antimicrobial Pharmacology/03.02 Azoles – Antifungals.mp430.32MB
21. 01. Antimicrobial Pharmacology/03.03 Polyenes – Antifungals.mp430.99MB
22. 01. Antimicrobial Pharmacology/03.04 Flucytosine (5-Fluorocytosine5-FU) – Antifungals.mp410.02MB
23. 01. Antimicrobial Pharmacology/03.05 Echinocandins and Squalene Epoxidase Inhibitor (Terbinafine) – Antifungals.mp413.45MB
24. 01. Antimicrobial Pharmacology/03.06 Questions – Antifungals.mp418.86MB
25. 01. Antimicrobial Pharmacology/04.01 Overview – Antiviral Drugs.mp416.95MB
26. 01. Antimicrobial Pharmacology/04.02 Anti-HIV Agents Fusion Inhibitors – Antiviral Drugs.mp49.62MB
27. 01. Antimicrobial Pharmacology/04.03 Anti-HIV Agents Nucleoside Reverse Transcriptase Inhibitors (NRTI) – Antiviral Drugs.mp457.3MB
28. 01. Antimicrobial Pharmacology/04.04 Anti-HIV Agents Reverse Transcriptase Inhibitors (NNRTI) – Antiviral Drugs.mp431.61MB
29. 01. Antimicrobial Pharmacology/04.05 Anti-HIV Agents Integrase Strand Transfer Inhibitors – Antiviral Drugs.mp415.16MB
30. 01. Antimicrobial Pharmacology/04.06 Anti-HIV Agents Protease Inhibitors – Antiviral Drugs.mp449.02MB
31. 01. Antimicrobial Pharmacology/04.07 Anti-HIV Agents CCR5 Antagonist – Antiviral Drugs.mp414.46MB
32. 01. Antimicrobial Pharmacology/04.08 Questions about Anti-HIV Agents – Antiviral Drugs.mp413.84MB
33. 01. Antimicrobial Pharmacology/04.09 Case Studies about Anti-HIV Agents – Antiviral Drugs.mp415.78MB
34. 01. Antimicrobial Pharmacology/04.10 Anti-Herpes Agents Thymidine Kinase Agents – Antiviral Drugs.mp435.04MB
35. 01. Antimicrobial Pharmacology/04.11 Anti-Herpes Agents RNA Polymerase Inhibitors and Other Drugs – Antiviral Drugs.mp423.04MB
36. 01. Antimicrobial Pharmacology/04.12 Influenza Treatment – Antiviral Drugs.mp415.35MB
37. 01. Antimicrobial Pharmacology/04.13 Hepatitis Treatment – Antiviral Drugs.mp444.01MB
38. 01. Antimicrobial Pharmacology/04.14 Overview – Antiviral Agents and Treatment of CMV Retinitis – Antiviral Drugs.mp411.88MB
39. 01. Antimicrobial Pharmacology/04.15 Case Study – Antiviral Drugs.mp441.6MB
40. 01. Antimicrobial Pharmacology/05.01 Antimalarial Drugs – Antiprotozoal Agents.mp488.71MB
41. 01. Antimicrobial Pharmacology/05.02 Amebicides – Antiprotozoal Agents.mp458.22MB
42. 01. Antimicrobial Pharmacology/05.03 Nematicides – Antihelmintic Drugs.mp436.54MB
43. 01. Antimicrobial Pharmacology/05.04 Trematocides (Praziquantel) and Cestodicides (Niclosamide) – Antihelmintic Drugs.mp415.42MB
44. 01. Antimicrobial Pharmacology/05.05 Questions – Antiprotozoal and Antihelmintic Drugs.mp420.58MB
45. 02. Pharmacokinetics and Pharmacodynamics/01.01 Introduction to Kinetics Pharmacokinetics (PK).mp432.04MB
46. 02. Pharmacokinetics and Pharmacodynamics/01.02 Hydrophilic vs. Hydrophobic – Absorption and Distribution Pharmacokinetics (PK).mp427.02MB
47. 02. Pharmacokinetics and Pharmacodynamics/01.03 pKa and Drug Solubility – Absorption and Distribution Pharmacokinetics (PK).mp436.57MB
48. 02. Pharmacokinetics and Pharmacodynamics/01.04 Drug Distribution – Absorption and Distribution Pharmacokinetics (PK).mp436.55MB
49. 02. Pharmacokinetics and Pharmacodynamics/01.05 Phases of Drug Development – Absorption and Distribution Pharmacokinetics (PK).mp438.58MB
50. 02. Pharmacokinetics and Pharmacodynamics/02.01 Drug Metabolism – Biotransformation Pharmacokinetics (PK).mp449.38MB
51. 02. Pharmacokinetics and Pharmacodynamics/02.02 Factors Affecting Drug Metabolism – Biotransformation Pharmacokinetics (PK).mp4108.04MB
52. 02. Pharmacokinetics and Pharmacodynamics/03.01 Introduction and Definitions of Pharmacodynamics – Pharmacodynamics.mp416.09MB
53. 02. Pharmacokinetics and Pharmacodynamics/03.02 Drug Receptors and Effectors – Pharmacodynamics.mp417.01MB
54. 02. Pharmacokinetics and Pharmacodynamics/03.03 Upregulation and Downregulation – Pharmacodynamics.mp45.39MB
55. 02. Pharmacokinetics and Pharmacodynamics/03.04 Dose-Response, Binding, Quantal, Toxicity & Potency Curves – Pharmacodynamics.mp472.49MB
56. 02. Pharmacokinetics and Pharmacodynamics/04.01 Introduction esp. Types of Eliminations – Elimination Kinetics.mp422.54MB
57. 02. Pharmacokinetics and Pharmacodynamics/04.02 First Pass Metabolism – Elimination Kinetics.mp413.43MB
58. 02. Pharmacokinetics and Pharmacodynamics/04.03 Bioavailability incl. Case Study – Elimination Kinetics.mp415.1MB
59. 02. Pharmacokinetics and Pharmacodynamics/04.04 Dosage Calculation Maintenance Dose and Loading Dose – Elimination Kinetics.mp435.64MB
60. 02. Pharmacokinetics and Pharmacodynamics/04.05 Intravenous vs. Oral Medications – Elimination Kinetics.mp48.71MB
61. 02. Pharmacokinetics and Pharmacodynamics/04.06 Renal Clearance – Elimination Kinetics.mp432.69MB
62. 03. Inflammation Pharmacology/01. Pharmacology of Inflammation.mp447.98MB
63. 03. Inflammation Pharmacology/02. Acetylsalicylic Acid (ASA).mp431.37MB
64. 03. Inflammation Pharmacology/03. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).mp420.6MB
65. 03. Inflammation Pharmacology/04. COX-2 Inhibitors.mp415.69MB
66. 03. Inflammation Pharmacology/05. Disease Modifying Anti Rheumatic Agents (DMARDS).mp444.98MB
67. 03. Inflammation Pharmacology/06. Gout Medication Colchicine, Uric Acid and More.mp442.54MB
68. 03. Inflammation Pharmacology/07. Inflammation Pharmacology Questions.mp427.3MB
69. 04. Endocrine Pharmacology/01.01 Insulin – Diabetes Medications.mp419.07MB
70. 04. Endocrine Pharmacology/01.02 Insulin Types & Glycemic Excursions – Diabetes Medications.mp425.11MB
71. 04. Endocrine Pharmacology/01.03 Secretagogues and Biguanides – Diabetes Medications.mp427.98MB
72. 04. Endocrine Pharmacology/01.04 Metformin, Alpha Glucosidase Inhibitors and Thiazolidinediones – Diabetes Medications.mp440.04MB
73. 04. Endocrine Pharmacology/01.05 DPP-4 Inhibitors and GLP-1 Analogues – Diabetes Medications.mp428.04MB
74. 04. Endocrine Pharmacology/01.06 SGLT2 Inhibitors – Diabetes Medications.mp450.16MB
75. 04. Endocrine Pharmacology/01.07 Questions – Diabetes Medications.mp459.92MB
76. 04. Endocrine Pharmacology/02.01 Overview – Adrenal Pharmacology.mp44.22MB
77. 04. Endocrine Pharmacology/02.02 Mineralocorticoids and Glucocorticoids – Adrenal Pharmacology.mp449.8MB
78. 04. Endocrine Pharmacology/02.03 Catecholamines – Adrenal Pharmacology.mp419.21MB
79. 04. Endocrine Pharmacology/02.04 Questions and Case Studies – Adrenal Pharmacology.mp422.57MB
80. 05. CNS - Pharmacology/01.01 Overview of Sedative and Hypnotic Drugs – Sedative Hypnotics.mp451.63MB
81. 05. CNS - Pharmacology/01.02 Benzodiazepines – Sedative Hypnotics.mp433.35MB
82. 05. CNS - Pharmacology/01.03 Barbiturates – Sedative Hypnotics.mp412.75MB
83. 05. CNS - Pharmacology/01.04 Atypical Antipsychotic Drugs – Sedative Hypnotics.mp454.38MB
84. 05. CNS - Pharmacology/01.05 Questions – Sedative Hypnotics.mp415.52MB
85. 05. CNS - Pharmacology/01.06 Case Study – Sedative Hypnotics.mp421.39MB
86. 05. CNS - Pharmacology/02.01 Overview – Antidepressants.mp414.49MB
87. 05. CNS - Pharmacology/02.02 Monoamine Oxidase Inhibitors (MAOIs) – Antidepressants.mp423.58MB
88. 05. CNS - Pharmacology/02.03 Tricyclic Antidepressants (TCAs) – Antidepressants.mp423.12MB
89. 05. CNS - Pharmacology/02.04 Heterocyclic Antidepressants – Antidepressants.mp414.3MB
90. 05. CNS - Pharmacology/02.05 SNRIs, Serotonin Antagonists and SSRIs – Antidepressants.mp452.57MB
91. 05. CNS - Pharmacology/02.06 Review – Antidepressants.mp47.24MB
92. 05. CNS - Pharmacology/02.07 Questions – Antidepressants.mp422.77MB
93. 05. CNS - Pharmacology/03.01 Overview – Antipsychotics.mp49.09MB
94. 05. CNS - Pharmacology/03.02 Effects of Increasing Dopamine – Antipsychotics.mp414.06MB
95. 05. CNS - Pharmacology/03.03 Bipolar Disorder Medication – Antipsychotics.mp431.3MB
96. 05. CNS - Pharmacology/03.04 Psychotic Disorder Medication – Antipsychotics.mp421.14MB
97. 05. CNS - Pharmacology/03.05 Clinical Uses of Antipsychotics and Drug Induced Dyskinesia.mp424.68MB
98. 05. CNS - Pharmacology/03.06 Questions – Antipsychotics.mp415.96MB
99. 05. CNS - Pharmacology/04.01 Dopamine Hypothesis – Medication of Movement Disorders.mp419.82MB
100. 05. CNS - Pharmacology/04.02 Dopamine Precursors and Agonists – Treatment of Movement Disorders.mp446.57MB
101. 05. CNS - Pharmacology/04.03 MAO and COMT Inhibitors – Treatment of Movement Disorders.mp421.99MB
102. 05. CNS - Pharmacology/04.04 Amantadine and Anticholinergics – Medication of Movement Disorders.mp416.48MB
103. 05. CNS - Pharmacology/04.05 Postural Tremor, Huntington's Disease, Tourette's Syndrome, Wilsons's Disease and Drug Induced Dyskinesia – Medication of Movement Dis.mp435MB
104. 05. CNS - Pharmacology/05.01 Overview – Anti-Seizure Medications.mp425.37MB
105. 05. CNS - Pharmacology/05.02 Treatment Strategies – Anti-Seizure Medications.mp465.55MB
106. 05. CNS - Pharmacology/05.03 Questions – Anti-Seizure Medications.mp422.01MB
107. 05. CNS - Pharmacology/06.01 Overview – Anesthetic Drugs.mp44.94MB
108. 05. CNS - Pharmacology/06.02 Inhaled Anesthetics – Anesthetic Drugs.mp430.42MB
109. 05. CNS - Pharmacology/06.03 General Anesthetics – Anesthetic Drugs.mp441.59MB
110. 05. CNS - Pharmacology/06.04 Intravenous Anesthetics – Anesthetic Drugs.mp424.45MB
111. 05. CNS - Pharmacology/06.05 Case Study – Anesthetic Drugs.mp421.78MB
112. 05. CNS - Pharmacology/07.01 Overview – Skeletal Muscle Relaxants.mp48.69MB
113. 05. CNS - Pharmacology/07.02 Neuromuscular Blockers – Skeletal Muscle Relaxants.mp434.55MB
114. 05. CNS - Pharmacology/07.03 Acute and Chronic Muscle Spasms – Skeletal Muscle Relaxants.mp433.21MB
115. 05. CNS - Pharmacology/07.04 Questions – Skeletal Muscle Relaxants.mp434.64MB
116. 05. CNS - Pharmacology/08.01 Overview – Local Anesthetics.mp439.75MB
117. 05. CNS - Pharmacology/08.02 Esters and Amides – Local Anesthetics.mp432.95MB
118. 05. CNS - Pharmacology/08.03 Overview – Opioid Analgesics.mp415.11MB
119. 05. CNS - Pharmacology/08.04 Opioid Agonists – Opioid Analgesics.mp432.95MB
120. 05. CNS - Pharmacology/08.05 Mixed AgonistsAntagonists and Antagonists – Opioid Analgesics.mp431.52MB
121. 05. CNS - Pharmacology/08.06 Questions – Local Anesthetics and Opioid Analgesics.mp432.84MB
122. 06. ANS - Pharmacology/01.01 Autonomic Nervous System (ANS) Overview.mp437.92MB
123. 06. ANS - Pharmacology/01.02 Dual Innervation.mp423.14MB
124. 06. ANS - Pharmacology/01.03 Alpha- and Beta-Blockers.mp430.18MB
125. 06. ANS - Pharmacology/01.04 Sympathetic Blockers.mp428.71MB
126. 06. ANS - Pharmacology/02.01 Cholinomimetic Activators.mp419.25MB
127. 06. ANS - Pharmacology/02.02 Cholinomimetic Effects.mp437.52MB
128. 06. ANS - Pharmacology/02.03 Special Topic Cholinergic Toxicity, Poisoning, Myestenia Crisis and Cholinergic Crisis.mp436.87MB
129. 06. ANS - Pharmacology/03.01 Sympathomimetic Activators.mp430.33MB
130. 06. ANS - Pharmacology/03.02 Sympathomimetic Effects.mp479.06MB
131. 06. ANS - Pharmacology/03.03 Global Effect of Sympathomimetic Drugs on the Vascular System.mp437.12MB
132. 06. ANS - Pharmacology/03.04 Anticholinergic Drugs.mp457.09MB
133. 07. Respiratory Pharmacology/01. Asthma Medications.mp414.35MB
134. 07. Respiratory Pharmacology/02. Bronchodilators.mp421.59MB
135. 07. Respiratory Pharmacology/03. Corticosteroids.mp414.4MB
136. 07. Respiratory Pharmacology/04. Leukotriene Receptor Antagonists.mp411.4MB
137. 07. Respiratory Pharmacology/05. Anti-Inflammatory Agents Release Inhibitors and IgE-Antibodies.mp412.96MB
138. 07. Respiratory Pharmacology/06. Asthma Medication Questions.mp416.18MB
139. 08. Pharmacology of Blood Coagulation/01. Overview Coagulant Drugs.mp45.71MB
140. 08. Pharmacology of Blood Coagulation/02. Antiplatelets.mp444.48MB
141. 08. Pharmacology of Blood Coagulation/03. Anticoagulants.mp469.01MB
142. 08. Pharmacology of Blood Coagulation/04. Thrombolytics and Procoagulants.mp439.01MB
143. 08. Pharmacology of Blood Coagulation/05. Questions Coagulant Drugs.mp421.55MB
144. 09. Gastrointestinal Pharmacology/01. Questions and Case Studies Steroids, Cyclosprine and Crohn's Disease.mp445.75MB
145. 09. Gastrointestinal Pharmacology/02 Inflammatory Bowel Disease Medication.mp476.62MB
146. 09. Gastrointestinal Pharmacology/03. Stomach Ulcer (Peptic Acid Disease) Medication.mp451.2MB
147. 09. Gastrointestinal Pharmacology/04. Motility Disorder Medication.mp453.93MB
148. 09. Gastrointestinal Pharmacology/05. Nausea Medication Antiemetics – Gastrointestinal Drugs.mp440.63MB
149. 09. Gastrointestinal Pharmacology/06. Pancreatic Enzyme Replacement Therapy (PERT) and Gallstone Prevention – Gastrointestinal Drugs.mp416.88MB
150. 09. Gastrointestinal Pharmacology/07. Irritable Bowel Syndrome (IBS) Medication.mp416.89MB
151. 09. Gastrointestinal Pharmacology/08. Questions and Case Studies H2 Blockers, GERD Medication and Domperidone.mp418.88MB
152. 10. Toxicology/03.05 Toxicology Questions & Case Studies.mp455.24MB
153. 11. Cardiovascular Pharmacology/01.01 Introduction to High Blood Pressure Medication – Drugs in Hypertension.mp49.76MB
154. 11. Cardiovascular Pharmacology/01.02 Diuretics – Drugs in Hypertension.mp456.44MB
155. 11. Cardiovascular Pharmacology/01.03 Renin Angiotensin Aldosterone – Drugs in Hypertension.mp458.57MB
156. 11. Cardiovascular Pharmacology/01.04 Vasodilators – Drugs in Hypertension.mp448.1MB
157. 11. Cardiovascular Pharmacology/01.05 Alpha Blockers – Drugs in Hypertension.mp411.74MB
158. 11. Cardiovascular Pharmacology/01.06 Beta Blockers – Drugs in Hypertension.mp429.15MB
159. 11. Cardiovascular Pharmacology/01.07 Postganglionic Sympathetic Nerve Terminal Blockers and Monoamine Oxidase Inhibitors – Drugs in Hypertension.mp413.39MB
160. 11. Cardiovascular Pharmacology/01.08 Lines of Therapy – Drugs in Hypertension.mp447.59MB
161. 11. Cardiovascular Pharmacology/01.09 Pulmonary Hypertension Medication – Drugs in Hypertension.mp416.51MB
162. 11. Cardiovascular Pharmacology/01.10 Questions and Case Studies – Drugs in Hypertension.mp433.77MB
163. 11. Cardiovascular Pharmacology/02.01 Introduction – Angina and Heart Failure Management.mp415.62MB
164. 11. Cardiovascular Pharmacology/02.02 Nitrates – Angina and Heart Failure Management.mp428.34MB
165. 11. Cardiovascular Pharmacology/02.03 Cardiac Depressants, Metabolic Modifiers and Slow Sodium Channel Inhibitors – Angina and Heart Failure Management.mp421.11MB
166. 11. Cardiovascular Pharmacology/02.04 Inotropes – Angina and Heart Failure Management.mp437.25MB
167. 11. Cardiovascular Pharmacology/02.05 Vasodilators – Angina and Heart Failure Management.mp418.01MB
168. 11. Cardiovascular Pharmacology/02.06 Renin-Angiotensin Agents and Beta Blockers – Angina and Heart Failure Management.mp415.14MB
169. 11. Cardiovascular Pharmacology/02.07 Questions – Angina and Heart Failure Management.mp439.23MB
170. 11. Cardiovascular Pharmacology/03.01 Introduction – Antiarrhythmic Drugs.mp44.45MB
171. 11. Cardiovascular Pharmacology/03.02 Group 1 Sodium Channel Blockers – Antiarrhythmic Drugs.mp432.74MB
172. 11. Cardiovascular Pharmacology/03.03 Group 2 Beta Blockers – Antiarrhythmic Drugs.mp411.81MB
173. 11. Cardiovascular Pharmacology/03.04 Group 3 Potassium Channel Blockers – Antiarrhythmic Drugs.mp423.91MB
174. 11. Cardiovascular Pharmacology/03.05 Group 4 Calcium Channel Blockers – Antiarrhythmic Drugs.mp412.02MB
175. 11. Cardiovascular Pharmacology/03.06 Group 5 Other Antiarrhythmics – Antiarrhythmic Drugs.mp424.87MB
176. 11. Cardiovascular Pharmacology/03.07 Questions – Antiarrhythmic Drugs.mp421.42MB
177. 11. Cardiovascular Pharmacology/04.01 Introduction Bile Acid Sequestrants, Niacin and Fibrates – Lipid Control.mp440.71MB
178. 11. Cardiovascular Pharmacology/04.02 HMG-CoA Reductase Inhibitors – Lipid Control.mp463.37MB
179. 11. Cardiovascular Pharmacology/04.03 Fat Absorption and MTP Inhibitors – Lipid Control.mp424.28MB
180. 11. Cardiovascular Pharmacology/04.04 PCSK9 Inhibitors – Lipid Control.mp455.59MB
181. 11. Cardiovascular Pharmacology/04.05 Questions – Lipid Control.mp418.96MB
182. 12. Reproductive Pharmacology/01. Overview – Reproductive Pharmacology.mp410.31MB
183. 12. Reproductive Pharmacology/02. Estrogens and Progestins – Reproductive Pharmacology.mp466.52MB
184. 12. Reproductive Pharmacology/03. Anti-Estrogens and Antiprogestins – Reproductive Pharmacology.mp441.68MB
185. 12. Reproductive Pharmacology/04. Androgens and Antiandrogens.mp440.67MB
186. 12. Reproductive Pharmacology/05. Questions and Case Studies – Reproductive Pharmacology.mp420.81MB